Human LATS1 activation kit by CRISPRa

CAT#: GA106068

LATS1 CRISPRa kit - CRISPR gene activation of human large tumor suppressor kinase 1



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (2)
Rabbit Polyclonal Anti-LATS1 Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


LATS1 (Myc-DDK-tagged)-Human LATS, large tumor suppressor, homolog 1 (Drosophila) (LATS1)
    • 10 ug

CNY 11,800.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol LATS1
Locus ID 9113
Kit Components

GA106068G1, LATS1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA106068G2, LATS1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA106068G3, LATS1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001270519, NM_004690, NR_073033, NM_001350339, NM_001350340, NM_001350392
Synonyms WARTS; wts
Summary The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq, Apr 2017]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...